Hisamitsu Pharmaceutical Co Price Prediction
| HTSUFDelisted Stock | USD 30.31 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Hisamitsu Pharmaceutical hype-based prediction, you can estimate the value of Hisamitsu Pharmaceutical Co from the perspective of Hisamitsu Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Hisamitsu Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Hisamitsu because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Hisamitsu Pharmaceutical after-hype prediction price | USD 30.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Hisamitsu |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hisamitsu Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hisamitsu Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Hisamitsu Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hisamitsu Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Hisamitsu Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Hisamitsu Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Hisamitsu Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hisamitsu Pharmaceutical's historical news coverage. Hisamitsu Pharmaceutical's after-hype downside and upside margins for the prediction period are 30.31 and 30.31, respectively. We have considered Hisamitsu Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Hisamitsu Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Hisamitsu Pharmaceutical is based on 3 months time horizon.
Hisamitsu Pharmaceutical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Hisamitsu Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hisamitsu Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hisamitsu Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
30.31 | 30.31 | 0.00 |
|
Hisamitsu Pharmaceutical Hype Timeline
Hisamitsu Pharmaceutical is currently traded for 30.31. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Hisamitsu is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Hisamitsu Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 30.31. About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hisamitsu Pharmaceutical last dividend was issued on the 27th of February 2023. The entity had 2:1 split on the 27th of June 2000. Assuming the 90 days horizon the next anticipated press release will be in a few days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.Hisamitsu Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Hisamitsu Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Hisamitsu Pharmaceutical's future price movements. Getting to know how Hisamitsu Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hisamitsu Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SGIOY | Shionogi Co Ltd | 0.00 | 0 per month | 0.00 | (0.24) | 1.63 | (2.09) | 5.10 | |
| OASMY | Oasmia Pharmaceutical AB | 0.00 | 0 per month | 0.00 | (0.04) | 0.00 | (42.86) | 190.00 | |
| CRDL | Cardiol Therapeutics Class | 0.23 | 6 per month | 0.00 | (0.09) | 5.62 | (5.73) | 19.95 | |
| TAK | Takeda Pharmaceutical Co | (0.07) | 11 per month | 0.00 | (0.28) | 1.21 | (1.91) | 4.86 | |
| BHC | Bausch Health Companies | 0.47 | 9 per month | 1.47 | 0.14 | 6.30 | (2.57) | 17.92 | |
| PBH | Prestige Brand Holdings | (0.21) | 11 per month | 1.04 | 0.07 | 1.90 | (1.76) | 5.58 | |
| AMPH | Amphastar P | (1.85) | 8 per month | 0.00 | (0.08) | 3.37 | (3.61) | 17.30 | |
| DCPH | Deciphera Pharmaceuticals LLC | 0.00 | 0 per month | 0.00 | (0.16) | 3.27 | (3.25) | 9.66 | |
| PCRX | Pacira BioSciences, | (0.35) | 9 per month | 2.13 | 0.03 | 3.96 | (3.67) | 10.38 | |
| COLL | Collegium Pharmaceutical | (0.86) | 8 per month | 0.00 | (0.17) | 3.23 | (4.47) | 12.29 |
Hisamitsu Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Hisamitsu price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hisamitsu using various technical indicators. When you analyze Hisamitsu charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Hisamitsu Pharmaceutical Predictive Indicators
The successful prediction of Hisamitsu Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Hisamitsu Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Hisamitsu Pharmaceutical based on analysis of Hisamitsu Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Hisamitsu Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hisamitsu Pharmaceutical's related companies.
Story Coverage note for Hisamitsu Pharmaceutical
The number of cover stories for Hisamitsu Pharmaceutical depends on current market conditions and Hisamitsu Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hisamitsu Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hisamitsu Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Hisamitsu Pharmaceutical Short Properties
Hisamitsu Pharmaceutical's future price predictability will typically decrease when Hisamitsu Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Hisamitsu Pharmaceutical Co often depends not only on the future outlook of the potential Hisamitsu Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hisamitsu Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.7 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Hisamitsu Pink Sheet
If you are still planning to invest in Hisamitsu Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hisamitsu Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |